Media Pack
News

Current Edition

Volume 6 Issue 3

Upcoming Events

Advertisement

 
 
news

Lilly puts $700M into genetic medicine institute

Dive Brief: Eli Lilly is again upping its investment in genetic medicine, announcing Tuesday plans to establish a Boston research center that will use RNA- and DNA...
24 February 2022 news $700M | genetic
Continue Reading →
news

Editas’ executive shake up continues

Dive Brief: Editas Medicine, a biotechnology company focused on CRISPR gene editing, has fired its chief medical officer, adding to a series of executive-level cha...
10 February 2022 news biotechnology | company
Continue Reading →
news

Incyte withdraws cancer drug from FDA review after discussions with regulator

Dive Brief: Incyte is pulling its application for an experimental lymphoma medicine after determining that the Food and Drug Administration's requirements for conf...
27 January 2022 news cancer | Drug
Continue Reading →
news

Roche revives a closely watched Huntington’s disease drug

Dive Brief: Roche has outlined a new clinical path forward for a closely watched Huntington's disease drug ten months after disappointing Phase 3 study results app...
20 January 2022 news Disease | Huntington
Continue Reading →
news

Moxidectin gets USFDA nod to treat River Blindness

 Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) have announce...
15 June 2018 news blindness | development
Continue Reading →
news

Haselmeier and Common Sensing Enter Connected Injectable Medicine Collaboration

Haselmeier, a Swiss-based developer and manufacturer of innovative self-injection devices, and Common Sensing, a Cambridge-based smart injector monitoring and support...
4 May 2018 news common | Haselmeier
Continue Reading →
 
 
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2023, All Rights Reserved – Powered by Teksyte